RetinaLyze International

RetinaLyze International Safe, fast and efficient retinal investigations with RetinaLyze AI and Telemedicine. Retinalyze is based on the vision to prevent loss of eyesight.

Worldwide diabetes is an increasing problem and +300 million registered diabetics (type 1 or 2) are expected in 2020. Furthermore by 2020 +250 million unregistered diabetics are expected. One of the most feared consequences of diabetes is retinal diabetic pathology since this can lead to blindness. Early diagnosis is crucial – and possible with Retinalyze. A good diabetic plan and a non-complicated laser treatment can prevent loss of sight and blindness. Our mission is to make it easier for people all over the world to have their eyes tested and prevent the tragic consequences caused by late treatment of retinal lesions. Retinalyze System A/S is a registered company in Denmark.

New year. New resolutions.We often promise ourselves to eat better, move more, and slow down.But one resolution is often...
31/12/2025

New year. New resolutions.

We often promise ourselves to eat better, move more, and slow down.
But one resolution is often overlooked – eye health.

A simple visit to your optometrist can help detect eye disease early, protect vision, and give peace of mind. Many conditions are silent until it’s too late.

In 2026, make eye care part of your health routine.

Your future self will thank you!

From all of us at RetinaLyze – wishing you a healthy, clear-sighted year ahead. 👀 ✨

29/12/2025

Happy New Year from all of us at RetinaLyze 🎉
Stay safe and protect your eyes!

Happy holidays from RetinaLyze System!
24/12/2025

Happy holidays from RetinaLyze System!

21/12/2025

You may have seen our Merry Christmas video last week, but did you see the bloopers in the end?

Hope you have as much as fun watching it, as we did making it 😂

2025 was a year of real clinical progress for RetinaLyze.Stronger science. Smarter integrations. Broader access to eye s...
17/12/2025

2025 was a year of real clinical progress for RetinaLyze.

Stronger science. Smarter integrations. Broader access to eye screening.

This year we:
- Expanded RetinaLyze Advanced Glaucoma with combined fundus + perimetry analysis
- Strengthened the scientific foundation behind GDF and ONH Hb with large-scale validation
- Deepened integrations with partners like Medibrix and Heidelberg Engineering
- Expanded clinical adoption through new and growing distribution partnerships across Europe and Latin America

Most importantly, everything we built in 2025 was aimed at one goal:
Making early, accessible eye-disease detection work in real clinical workflows.

We’ve wrapped the highlights, evidence, and what’s next into a short Year in Review blog post.

👉 Read it here: https://retinalyze.com/company-news/retinalyze-year-in-review-2025-a-year-of-strong-science-new-integrations-global-momentum/

Thank you to all clinicians, researchers, distributors, and partners shaping the future of eye screening with us.

Happy holidays!

15/12/2025

A thank you and happy holidays to all friends, customers, distributors and partners from your friends at RetinaLyze! 🎄

10/12/2025

AI has quietly become a thinking partner in every eye exam.

Not a tool.
Not an add-on.

A parallel stream of reasoning that sees patterns we can’t and compares thousands of patient cases in an instant.

That’s more than “assistance.”
It’s a cognitive shift.

And it raises an uncomfortable but important question:
If AI now contributes to the clinical reasoning process… what defines our expertise going forward?

AI is evolving faster than optometry education is adapting.

To thrive in this new landscape, clinicians need other skills:
- Understanding uncertainty
- Challenging algorithmic and personal bias
- Knowing when to trust the system and when to override it

Equally essential are the human skills AI will never replace: Reading fear in a patient’s expression, Turning risk into reassurance, Translating data into decisions patients can understand and act on.

AI can’t do any of that.

And that’s exactly why the role of the clinician is becoming more, not less, important. If we don’t evolve, we risk letting technology set the pace instead of shaping how it’s used.

Optometry needs training built for a world where humans and AI share the diagnostic load.

Glaucoma rarely shows its full hand in one test. Combining structural and functional data is important for a full diagno...
08/12/2025

Glaucoma rarely shows its full hand in one test. Combining structural and functional data is important for a full diagnosis.

With RetinaLyze Glaucoma, we’re taking a simple but powerful step in that direction: letting clinicians pair retinal image analysis with visual field results from devices like Haag-Streit Octopus, OCULUS, and ZEISS Medical Technology Humphrey.

When you connect the dots between fundus findings and perimetry, the picture becomes clearer:
- Subtle nerve fibre changes suddenly match subtle field losses
- Early damage becomes easier to spot
- Follow-up decisions feel more confident for both optometrists and ophthalmologists

You can easily add VF indices to the analysis for a more complete overview. Differences between TOP, SPARK, and SITA strategies are handled behind the scenes. Newer metrics, like the TCV harmony index, offer another lens on early functional change.

No complex workflows. No new hardware. Just a smarter way to bring two important data sources together.

04/12/2025

As AI becomes part of the everyday toolkit in optometry and ophthalmology, one question keeps coming up: can we actually see why it reached its conclusion?

If we can’t, it feels like a black box.

If we can, it suddenly becomes something much more useful. A teaching aid, a conversation starter, and a real time-saver.

For educators, explainable AI turns every screening into an opportunity to learn. Students and new grads can follow along and understand what the AI spotted and why it mattered.

For optometrists, this transparency makes it easier to talk through results with patients and to send clear, confident referrals.

For ophthalmologists and graders, having visual evidence right on the image means less time figuring out how the AI got there and more time simply confirming or rejecting the finding.

At RetinaLyze, this kind of clarity is what we're aiming for. A couple of examples:

Overlays in DR, AMD, and glaucoma screening:
The system highlights the exact areas where potential changes were detected. Nothing hidden, nothing vague.

Just clear visual cues that show the “why.” These overlays also make communication between optometrist and ophthalmologist much smoother, because everyone is literally looking at the same thing.

A deeper look at the optic nerve head:
Our glaucoma module analyzes the colour composition of the ONH to estimate local haemoglobin distribution. That information is then visualized in a way that’s intuitive to interpret, helping clinicians see structural patterns and perfusion-related changes at a glance.

Together, these tools help reduce review times, improve consistency, and support better conversations. Whether you’re in a lecture hall, an optical store, or a specialist clinic.

One year ago, Patrick and Kevin Körbs took the leap and introduced eye screening with RetinaLyze in their optical stores...
01/12/2025

One year ago, Patrick and Kevin Körbs took the leap and introduced eye screening with RetinaLyze in their optical stores in Ansbach and Eichstätt.

Today, their team can barely imagine working without it.

Their customers love getting fast, reliable results and the Körbs brothers love how seamlessly AI supports their daily workflow without complicating their core business of selling glasses and contact lenses.

On December 2nd at 7 p.m., Patrick and Kevin will share what the past year has really looked like:
• How they use AI to guide customers who struggle to get ophthalmology appointments
• How screening has boosted customer satisfaction and created new touchpoints
• How their 10-person team integrates RetinaLyze into consultations without slowing anything down
• Why they believe opticians should stay in the driver's seat when it comes to eye health

If you enjoy practical insights directly from colleagues, this is the webinar to join.

And even if you're still skeptical about AI in optometry, the Körbs brothers might just change your mind 😉
🔗 Register here (free): https://us02web.zoom.us/webinar/register/2617642552186/WN_isLaQ_8VSsyq988nc2zYOQ #/registration

Can't attend? Everyone who signs up will receive the recording automatically.

Hosted by Barbara Anthonsen Wohlgemuth & Michael Anthonsen – RetinaLyze DACH
Moderated by Ingo Rütten (Partnerauge Akademie)

We look forward to seeing you there and learning from two enthusiastic colleagues who’ve turned AI-powered eye screening into happier customers!

We’re excited to share that RetinaLyze System A/S has entered into a new partnership with FE-Group srl, bringing our AI-...
27/11/2025

We’re excited to share that RetinaLyze System A/S has entered into a new partnership with FE-Group srl, bringing our AI-powered eye screening software to clinics and optical practices across Italy.

This collaboration strengthens our mission to support earlier detection of eye diseases - now with the help of a trusted Italian distributor known for their deep expertise in ophthalmic and optometric technologies.

With their strong nationwide network, FE-Group srl will provide Italian eye-care professionals with local onboarding, workflow support, and access to CE-certified AI tools designed to make screening faster, safer and more consistent.

A warm thank you to the entire FE-Group team. We’re looking forward to helping optometrists, ophthalmologists and optical retailers across Italy elevate preventive eye care and deliver even better outcomes for patients.

Have data? Have an idea?Let’s create something new.We’re inviting healthcare specialists and researchers to collaborate ...
24/11/2025

Have data? Have an idea?
Let’s create something new.

We’re inviting healthcare specialists and researchers to collaborate with RetinaLyze on the next generation of eye-care solutions.

If you’re sitting on a dataset or a concept with potential impact, we’d love to explore it with you.

Fill out the form and let’s start a conversation that could move eye care forward!

https://retinalyze.com/collaborate-on-ai-development/

Adresse

Mileparken 10C
Skovlunde
2740

Åbningstider

Mandag 09:00 - 17:30
Tirsdag 09:00 - 17:30
Onsdag 09:00 - 17:30
Torsdag 09:00 - 17:30
Fredag 09:00 - 17:30

Internet side

Underretninger

Vær den første til at vide, og lad os sende dig en email, når RetinaLyze International sender nyheder og tilbud. Din e-mail-adresse vil ikke blive brugt til andre formål, og du kan til enhver tid afmelde dig.

Kontakt Praksis

Send en besked til RetinaLyze International:

Genveje

Del

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Prevention of blindness through AI

RetinaLyze prevents loss of eyesight by making eye screening accessible. 80% of all blindness is preventable. Early screening and diagnosis is crucial and possible with Retinalyze'​ automated retinal screening tools and telemedicine solutions. Our mission is to make it easier for people all over the world to have their eyes tested and prevent the tragic consequences caused by late treatment of retinal lesions.

RetinaLyze® is a screening software, which helps eye care professionals perform screenings for eye diseases in a safe and efficient manner. The automated algorithm (AI) module detects eye diseases by analyzing fundus images. It can be used as a clinical decision support system (CDSS) or as a screening tool in conjunction with the telemedicine module. Retinalyze System A/S is a registered company in Denmark. Check us out at https://RetinaLyze.com.